Regulation of CCN2 by CCN3 and its therapeutic and diagnostic potential in fibrosis, sclerosis and other diseases

Details for Australian Patent Application No. 2006203851 (hide)

Owner Rosalind Franklin University of Medicine and Science

Inventors Perbal, Bernard; Riser, Bruce L.

Agent Freehills

Pub. Number AU-B-2006203851

PCT Pub. Number WO2006/074452

Priority 60/642,728 10.01.05 US

Filing date 10 January 2006

Wipo publication date 13 July 2006

Acceptance publication date 12 April 2012

International Classifications

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 13/00 (2006.01) Drugs for disorders of the urinary system

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

23 August 2007 PCT application entered the National Phase

  PCT publication WO2006/074452 Priority application(s): WO2006/074452

12 April 2012 Application Accepted

  Published as AU-B-2006203851

9 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006203853-Door handle sanitizer system and valve attachment apparatus

2006203850-Targeted chimeric molecules for cancer therapy